About
About Shenzhen Lifotronic Technology Co., Ltd
Shenzhen Lifotronic Technology Co., Ltd. researches, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. It offers a comprehensive range of in vitro diagnostic equipment and reagents, including electrochemiluminescence immunoassay analyzers, glycated hemoglobin analyzers, specific protein analyzers, blood analyzers, and related testing reagents, serving hospitals, health check-up centers, and third-party medical testing institutions. The company also provides clinical medical solutions, such as intelligent venous thromboembolism (VTE) prevention systems, wound treatment devices, precision medicine equipment, and pain rehabilitation products for medical institutions; dermatological aesthetics, such as pulsed light therapy devices, shock wave therapy devices, laser therapy machines, and other energy-based medical aesthetic equipment; and therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products. In addition, the company provides medical and aesthetic, and laser hair removal products, as well as offers E-training services. Further, it offers medical and beauty-related products. Additionally, the company exports its products. Shenzhen Lifotronic Technology Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China.
Research context
Shenzhen Lifotronic Technology Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Shenzhen Lifotronic Technology Co., Ltd is currently in a long term uptrend where the price is trading 18.7% above its 200 day moving average.
From a valuation standpoint, the stock is 40.2% more expensive than other stocks from the None sector with a price to sales ratio of 17.4.
Shenzhen Lifotronic Technology Co., Ltd's total revenue rose by 30.4% to $161M since the same quarter in the previous year.
Its net income has increased by 48.1% to $51M since the same quarter in the previous year.
Based on the above factors, Shenzhen Lifotronic Technology Co., Ltd gets an overall score of 3/5.